Knowles Director Cheryl L. Shavers sold 6,618 shares worth $260,000 on August 17, 2026, reducing her direct holdings by 16%. Despite the sale, Shavers retains 35,723 shares valued at $1.3 million, indicating continued alignment with shareholders. The sale appears to be a routine profit-taking move following the stock's strong 92% one-year performance. Analysts remain bullish with 80% rating it as a buy and a median price target of $44.

Viavi Solutions (VIAV) reported robust Q4 fiscal 2026 results with revenue surging 52.5% to $443.1M and adjusted EPS jumping 161.5% to 34 cents, beating consensus estimates. AI data centers now account for roughly half of NSE segment revenues. The company guided Q1 revenue to $450-460M and non-GAAP EPS to 40-42 cents, signaling continued momentum. The Spirent acquisition and aerospace & defense business provide additional growth drivers.

The article highlights three underappreciated semiconductor companies positioned to benefit from the AI boom: Cirrus Logic (up 44.5% YTD) with strong Apple partnerships and attractive valuation; Qorvo (up 14% YTD) providing RF solutions for 5G and AI data centers with merger synergies; and Knowles (up 55.3% YTD) specializing in audio and medtech components for AI-driven devices. All three offer compelling growth opportunities with analyst support and strong fundamentals.

Interlink Electronics has appointed Darren Whittaker as European Business Development Director to support its organic growth strategy across Europe. Whittaker brings over 20 years of high-tech sales experience, including a track record of significantly increasing revenue at previous positions. The hire is part of Interlink's broader strategy to expand its global presence in sensor technology and printed electronics solutions.

Harvey Partners initiated a $14.5 million stake in Knowles Corporation, acquiring 622,500 shares in Q3. The company, which specializes in micro-acoustic components for various industries, has outperformed the S&P 500 with a 20% stock gain over the past year.

Syntiant Corp. received Octane's High Tech Award for 'Deal of the Year' after acquiring Knowles Corporation's Consumer MEMS Microphone business, expanding its edge AI technology and market presence.

Knowles Corporation reported strong Q2 2025 financial results, with revenue of $146 million (up 8% year-over-year), EPS of $0.24, and robust performance across MedTech and Precision Devices segments. The company expects continued growth and is expanding into specialty film and inductor product lines.

Knowles reported Q2 2025 earnings exceeding analyst expectations, with $145.9 million in revenue, representing a 7.9% year-over-year increase. The company demonstrated strong performance in Precision Devices segment and improved cash flow, with adjusted free cash flow rising 70.7%.

Syntiant CEO Kurt Busch has been named a 2025 Silver Stevie® Award winner for 'Technology Executive of the Year' in the 23rd Annual American Business Awards®. The award recognizes Busch's leadership in driving innovation and growth, including Syntiant's acquisition of Knowles Corporation's Consumer MEMS Microphones business.

Syntiant Corp. has completed the acquisition of Knowles Corporation's Consumer MEMS Microphones (CMM) business for $150 million in cash and stock. The acquisition expands Syntiant's product portfolio and strengthens its position in the MEMS microphone market.

Syntiant Corp. announced it will acquire Knowles' Consumer MEMS Microphones (CMM) business, a leading manufacturer of MEMS microphones. The acquisition will enable Syntiant to offer customers a complete turnkey solution for always-on audio and speech applications, combining MEMS microphones with the company's existing AI capabilities.

Gainers Benson Hill, Inc. (NYSE: BHIL) shares jumped 48.1% to $0.3740. Seres Therapeutics, Inc. (NASDAQ: MCRB) climbed 45.9% to $1.20. Seres Therapeutics, on Thursday, posted a narrower-than-expected quarterly loss. Qurate Retail, Inc. (NASDAQ: QRTEA) surged 44% to $0.6181 following third-quarter results. Cooper-Standard Holdings Inc. (NYSE: CPS) shares climbed 41% to $17.94 following better-than-expected third-quarter results. Tenon Medical, Inc. (NASDAQ: TNON) shares climbed 39.6% to $1.20 after the company announced it passed an FDA Level 2 Inspection. Udemy, Inc. (NASDAQ: UDMY) surged 38.1% to $12.46 following strong quarterly earnings. Vivakor, Inc. (NASDAQ: VIVK) climbed 32.7% to $0.77. Alpha Technology Group Limited (NASDAQ: ATGL) gained 32.5% to $6.64. Alpha Technology Group recently announced the closing of its initial public offering of 1,750,000 ordinary shares at a public offering price of $4.00 per share. Werewolf Therapeutics, Inc. (NASDAQ: HOWL) rose 29.8% to $2.7888. Werewolf Therapeutics released preliminary results from initial monotherapy dose-escalation cohorts of an ongoing Phase 1/1b trial of WTX-124 in patients with advanced or metastatic solid tumors. Enlivex Therapeutics Ltd. (NASDAQ: ENLV) jumped 28.5% to $1.8250. Syra Health Corp. (NASDAQ: SYRA) gained 27.8% to $1.5981. Dermata Therapeutics, Inc. (NASDAQ: DRMA) rose 26% to $0.76. Redfin Corporation (NASDAQ: RDFN) climbed 25.2% to $6.35 following third-quarter results. Phoenix Motor Inc. (NASDAQ: PEV) gained 25% to $0.93. DarioHealth Corp. (NASDAQ: DRIO) gained 24.7% to $1.2601. CVRx, Inc. (NASDAQ: CVRX) climbed 24.7% to $16.99. CVRx said Centers for Medicare and Medicaid Services has reassigned the Barostim implant procedure for procedures performed in the outpatient setting as part of the 2024 Medicare Hospital Outpatient Prospective Payment System final rule. Net Lease Office Properties (NYSE: NLOP) gained 24% to $12.98. Proto Labs, Inc. (NYSE: PRLB) climbed 23.1% to $29.93. Proto Labs reported third-quarter FY2 revenue growth of 7.4% ...